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Neuroinvasiveness is a property of all neurovirulent murine retroviruses, although the factors which facilitate infection
of the CNS are not understood. We previously showed that mutant MuLV which lack expression of an accessory protein,
glycosylated gag, had lost neurovirulence, indicating that this protein may be involved in promoting CNS infection. The
mutations were located in the ‘‘Kozak’’ consensus sequence of the initiation codon for this protein. Here it is shown that
shortly after inoculation of mice with one of these mutant viruses, revertants emerged which had regained expression of
glycosylated gag and had also regained the neuroinvasiveness and neurovirulence exhibited by the wild-type virus. The
phenotypic revertants retained the mutations in the ‘‘Kozak’’ consensus sequence but exhibited a G r A mutation 12 codons
downstream from the mutated start site, creating a new initiation codon and a glycosylated gag protein, which was truncated
at its N-terminus. Using antibodies specific for glycosylated gag it is shown that the frequency of splenic infectious centers
expressing revertant virus increased progressively during the 2 months following inoculation of mutant virus until ⁄50% of
the virus-producing cells in the spleen expressed revertant virus. In contrast, although phenotypic revertants were detectable
at low frequency after cell-free passage in vitro in M. dunni fibroblasts, there was no evidence for selection. These results
indicate that glycosylated gag facilitates virus spread within the spleen and to extra-splenic sites, such as the CNS, and
suggest that the protein may function through its interaction with the host. q 1996 Academic Press, Inc.
INTRODUCTION minal extracellular domain containing the bulk of the gag
polyprotein as well as the asparagine-linked glycosyla-
C-type viruses such as MuLV’s are considered ‘‘simple’’
tion sites.
retroviruses. They lack the complex splicing patterns of
Expression of glycosylated gag has been interrupted
the lentiviruses and do not depend on the expression of
by introduction of stop codons between the start sites of
the variety of accessory proteins so critical to the efficient
pr75gag and pr65gag (Fan et al., 1983; Corbin et al., 1994;
replication and spread of the lentiviruses. However, one
Schwartzberg et al., 1983). These experiments have dem-
accessory protein, glycosylated gag, has been identified
onstrated that glycosylated gag is dispensable for virus
in ‘‘simple’’ retroviruses, and it is generally expressed in
replication, although some evidence suggests that the
abundance at the surface of infected cells.Glycosylated
protein may influence the kinetics of virus spread (Corbin
gag is a nonstructural protein encoded by replication
et al., 1994). However, with one exception (Fan et al.,
competent murine (Snyder et al., 1977; Ledbetter et al., 1983), the stop codons have been introduced by frame-
1977; Evans et al., 1977) and feline (Neil et al., 1980) shift mutation achieved either by deletion (Schwartzberg
oncornaviruses. The protein is translated from generally et al., 1983) or insertion of exogenous DNA (Corbin et
a weak initiation codon upstream of, and inframe with, al., 1994) within the leader sequence of the viral genome.
the initiation codon for pr65gag, the precursor of the viral Since this region of the viral genome is involved in sev-
gag proteins which are constituents of the virus core. eral overlapping functions such as viral RNA dimerization
This upstream start site lies within the leader sequence (Prats et al., 1990), packaging (Mann and Baltimore, 1985;
of the viral RNA and creates a unique N-terminus of 70– Mann et al., 1983), and translation initiation (Vagner et
90 residues yielding a protein of approximately 75 kDa al., 1995; Berlioz and Darlix, 1995) it is not clear whether
(pr75gag). Based on both computer analysis (Nakai and mutations which interrupted expression of glycosylated
Kanehisa, 1992) as well as immunochemical studies (Pil- gag also interfered with one of these other functions of
lemer et al., 1986) the protein appears to be a Type II the 5* leader sequence. Thus, the effect of interrupting
transmembrane protein with an uncleaved signal-anchor the expression of this protein has not yet been clearly
sequence, an N-terminal cytoplasmic domain, and C-ter- defined.
We generated mutants of a neurovirulent murine retro-
virus CasFrKP which did not express glycosylated gag1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (406) 363-9204. E-mail: john_portis@nih.gov. (Portis et al., 1994). Our strategy was to interrupt protein
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expression without altering the sequence downstream tion were detected 3 days later on live cells with antibody
667 or on ethanol fixed cells using anti-4215 anti-peptideof the site of translation initiation. This was done by mu-
tating the ‘‘Kozak’’ consensus sequence (Kozak, 1989) antibody.
about the start codon of pr75gag. One of the mutants,
Limiting dilution cloning of revertant virusCasFrKP[03/4] (abbreviated [03 / 4]) carries an A r T
mutation at the 03 position of the consensus and a G In one experiment mice were bled from the retroorbital
r C mutation at the /4 position. No gag protein was sinus 155 days after neonatal inoculation of mutant virus
detectable at the surface of cells infected with this virus [03 / 4]. The sera was used to infect M. dunni cells,
and the virus had lost neurovirulence (Portis et al., 1994). from which virus stocks were prepared as described pre-
Whereas the kinetics of virus replication of the mutant viously (Portis et al., 1990). The stocks contained a mix-
in vivo was clearly slowed compared to wild-type virus, ture of both ecotropic MuLV (titered by focal immunoas-
curiously no effect of the mutation on virus replication say with monoclonal antibody 667) and polytropic virus,
was observed in vitro in fibroblast cell lines (Portis et al., assayed with monoclonal antibody 514 (see above). The
1994). This suggested that the function of glycosylated titer of the polytropic virus was approximately 100-fold
gag may involve a specific interaction with the host. lower than the ecotropic virus, making it possible to elimi-
The current study was undertaken to further address nate the polytropic virus by two sequential rounds of
the role of this protein in neuroinvasiveness. The results limiting dilution cloning on M. dunni cells. The absence
indicate that second-site revertants were generated very of polytropic virus was verified by titration with antibody
rapidly after inoculation of mutant virus [03 / 4], during 514. Because the tempo of the neurological disease in-
the phase of virus spread within hematopoietic organs, duced by cloned and uncloned virus stocks were indistin-
and these revertants were selected in vivo. Furthermore, guisable, the clinical data presented in Fig. 2 for revertant
the revertants had regained the neuroinvasiveness of the virus was pooled.
wild-type virus and also caused neurological disease,
providing solid evidence that glycosylated gag is an im- Immunoblot analysis
portant determinant of neuroinvasiveness. Interestingly,
M. dunni cells (2 1 105) were seeded into 60-mmalthough revertants were generated in vitro, they were
dishes in RPMI1640 plus 10% fetal calf serum and werenot selected, an observation which is consistent with
mass infected with 1–4 1 106 focus-forming units ofthe hypothesis that the function of glycosylated gag is
MuLV in the presence of 8 mg/ml Polybrene as describeddependent on its interaction with the host.
previously (Portis et al., 1994). After two passages at 1:5
and growth to confluence, the cells were washed with
MATERIALS AND METHODS ice-cold Dulbecco’s PBS and lysed with 2 ml 0.5% NP-
40 in 0.01 M Tris–HCL pH7.4, 0.15 M NaCl, and 0.001Mice, virus inoculations, and clinical evaluations
M EDTA for 5 min on ice. Lysates were centrifuged for
Inbred Rocky Mountain White (IRW) mice (Portis et al., 2 min in a Beckman Microfuge to pellet any nuclei which
1990), bred and raised at the Rocky Mountain Labs, were had lifted from the dish. SDS, 2ME, and glycerol were
inoculated with 30l of virus stock intraperitoneally (ip) at added to final concentrations of 2, 5, and 10%, respec-48 hr postnatally. Inocula contained 3–6 1 104 focus- tively, and the lysate boiled 5 min. Generally 10 ml of
forming units of infectivity (Czub et al., 1992). The mice lysate was separated in 9% SDS–polyacrylamide gels,
were allowed to develop undisturbed until 12 days post- and the gels were electroblotted onto Immobilon P mem-
inoculation (dpi) at which time they were observed for branes (Millipore), probed with antibodies, and devel-
signs of neurologic disease on a daily basis until 30 oped with ECL (Amersham) as described previously
dpi. Thereafter, mice were examined twice a week until (Czub et al., 1994). Antibodies used in immunoblots in-
approximately 150 days at which time the experiments cluded rabbit anti-CA (p30gag) (Czub et al., 1994) and
were terminated. Clinical evaluations were carried out rabbit anti-peptide antisera, the production of which is
as described previously (Czub et al., 1994). described below. Peptide N-Glycosidase F (PNGase)
was used to remove N-linked carbohydrates. Lysates in
Titration of viremia and splenic infectious centers sample buffer were incubated with the enzyme according
to the manufacturer’s (New England Biolabs) instructions.Virus in serum was quantified by focal immunoassay
as described previously (Czub et al., 1991) using mono-
Southern blot analysis for viral DNA
clonal antibody 667, specific for the SU (gp70) protein of
the ecotropic virus CasBrE (McAtee and Portis, 1985), Mice were inoculated ip at 24–48 hr postnatally and
killed by exsanguination under deep inhalation anesthe-and 514, specific for envelope protein of polytropic MuLV
(Chesebro et al., 1983). Splenic infectious centers were sia. Spleens and brains were removed and DNA ex-
tracted as described previously (Portis et al., 1990). DNAquantified by seeding dilutions of splenocytes onto M.
dunni cells as described (Czub et al., 1991). Foci of infec- was digested with BamHI, which excises an internal frag-
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ment from the envelope gene, blotted onto nitrocellulose,
and probed with a 32P-labled env-specific probe, WMXB,
as described (Portis et al., 1990).
DNA sequencing
M. dunni cells were seeded at 104 cells per 35-mm
dish and the next day were infected in the presence of
8 mg/ml Polybrene. The cells were passaged two or three
times 1:5 and when confluent, total cellular DNA was
extracted as described previously (Portis et al., 1990).
PCR amplification of the leader sequence of the proviral
genome from nucleotide 218 to nucleotide 771 (based
FIG. 1. Immunoblot analysis of gag proteins expressed by M. dunnion the numbering of the genome of FMuLV strain FB29
cells infected with KP or [03 / 4]. Proteins were separated on 9%No. Z11128) was carried out with the 5* oligonucleotide
PAGE gels and electroblotted. Proteins were detected with rabbit anti-
5*TTGCCATCCGACGTTGAAGG3* and the 3* oligonucle- CA antiserum and the ECL detection system (Amersham). Note the
otide 5*CAACTGATCTGTGTCTGTCC3* as primers. The absence of gp85gag in the lysate of [03 / 4] infected cells (A). In B a
lysate of KP-infected cells was treated with PNGase to remove N-linkedconditions of amplification were 30 sec. at 957, 30 sec
sugars. Note that the only gag protein that shifted in molecular sizeat 507, and 1 min at 727 for 25 cycles. The bulk PCR
was the gp85gag, which exhibited a molecular size consistent with thatproduct was sequenced without further cloning using the
of pr75gag, the precursor of glycosylated gag (Schultz et al., 1981; Ed-
above primers and the dideoxy method as described wards and Fan, 1980).
previously (Portis et al., 1994).
Ig (Cappel), respectively. Photomicrographs were takenProduction of anti-peptide antibodies to the N-
on a Nikon Microphot SA microscope.terminal sequence of glycosylated gag
Two anti-peptide antisera were used in these studies. RESULTS
Peptide 4210 corresponding with residues 1–18 (LGD-
Characterization of the glycosylated gag mutant [03VPGTSGAIFVARPES) and peptide 4215 corresponding
/ 4] by immunoblot analysiswith residues 15–35 (RPESNHPDRFGLFGAPPLEEG)
were synthesized by the Peptide Synthesis Laboratory Our initial characterization of the mutants utilized flow
of the Laboratory of Molecular Structure, NIAID. A cys- cytometry to quantify cell-surface expression of gag pro-
teine was added to the C-terminus of peptide 4210 and tein. It was therefore of interest to use a more rigorous
to the N-terminus of peptide 4215 and the peptides were detection technique to verify the lack of expression of
conjugated to keyhole limpet hemocyanin using m-malei- the protein. NP-40 lysates of M. dunni cells infected with
midobenzoyl-N-hydroxysuccinimide ester (Pierce) ac- mutant virus [03 / 4] were compared with wild-type
cording to the manufacturer’s instructions. Rabbits were virus [KP] by immunoblot analysis for expression of gly-
immunized with antigen emulsified in Complete Freund’s cosylated gag protein (Fig. 1). The blots were probed
adjuvant and boosted with antigen either in incomplete with a rabbit antiserum to CA protein (p30gag). Four CA-
Freund’s adjuvant or in saline. containing proteins were detected in the lysate of KP-
infected cells: CA protein itself, pr65gag (the precursor of
Immunohistochemistry the viral core proteins (Dickson et al., 1984)), p55gag (a
partial cleavage product of pr65gag (Dickson et al., 1984)),Mice were inoculated ip as neonates with either KP
and a protein with a molecular size of approximately 85or [03 / 4]. At various times after inoculation, mice were
kDa. The latter protein was missing in the lysate of [03killed by axillary exsanguination under Metofane anes- / 4]-infected cells. After treatment with the endoglycosi-thesia and their spleens were removed. Six-micrometer
dase PNGase to remove N-linked sugars (Fig. 1B), onlyfrozen sections were made with a Reichert Histostat
this 85-kDa band was found to shift its migration, indicat-Cryostat and the sections were air dried before fixing for
ing that it contained N-linked sugars and thus repre-5 min in acetone at room temperature. Sections were
sented glycosylated gag (designated gp85gag).incubated for 30 min at room temperature with primary
antibodies consisting of either biotinylated anti-SU mono-
Detection of revertants in mice chronically infected
clonal antibody 667 or anti-peptide 4210 or 4215 rabbit
with [03 / 4]
antisera. Monoclonal antibody 667 was biotinylated with
biotin-xx-succinimidyl ester (Molecular Probes). Sections Mice neonatally inoculated with KP develop a fatal
neurologic disease with an incubation period of 16– 20were washed three times in PBS and incubated with
FITC-avidin (Becton–Dickinson) or FITC-goat anti-rabbit days, whereas mice inoculated with [03 / 4] remain
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FIG. 2. Cumulative incidence of neurologic disease observed in IRW
mice inoculated neonatally with KP (n  14), 293 (n  30), or [03 /
4] (n  12). The data for 293 was pooled including 21 mice inoculated
with uncloned virus isolated from serum and 9 mice inoculated with
biologically cloned 293 (see Materials and Methods).
disease-free for 150 days (Portis et al., 1994). At 155
days postinoculation (dpi) three [03/ 4]-inoculated mice
were bled and their sera used to infect M. dunni cells
from which virus stocks were prepared. Unlike [03 / 4],
FIG. 4. Immunoblot analysis of NP-40 extracts of M. dunni cellstwo of the three stocks, when inoculated into neonatal infected with KP or the phenotypic revertant 293 and probed with rabbit
IRW mice caused neurologic disease, and one of these anti-CA antiserum. Note that 293 expressed levels of gp85gag equivalent
(stock 293) induced disease with nearly as short an incu- to that of KP.
bation period as did wild-type virus KP (Fig. 2).
The relative neuroinvasiveness of virus 293 was com-
was found in the CNS (C) only in mice inoculated withpared with that of the [03 / 4] mutant and wild-type
the wild-type and 293 viruses. Thus, the reversion tovirus KP by Southern blot analysis of DNA extracted from
neurovirulence of 293 was associated with a recovery ofthe brains of neonatally inoculated mice 14 days postin-
neuroinvasiveness which had been lost in the [03 / 4]oculation (Fig. 3). Viral DNA was detected in the spleens
mutant. Immunoblot analysis of lysates of M. dunni cells(S) of mice infected with all three viruses, but viral DNA
infected with the biologically cloned 293 virus contained
gp85gag at levels similar to wild-type virus KP (Fig. 4),
suggesting that the neuroinvasiveness of the revertant
293 was a consequence of a restored expression of gly-
cosylated gag.
Basis of the phenotypic reversion
In order to determine the basis of the phenotype rever-
sion of mutant [03 / 4], PCR sequence analysis was
performed on DNA extracted from M. dunni cells infected
with the biologically cloned 293 virus. The sequence (Fig.
5A) revealed that the mutations within the ‘‘Kozak’’ con-
sensus sequence about the CTG initiation codon of [03
/ 4] were preserved (A r T at position 03 and G r C
at position /4 of the consensus). Twelve codons 3* ofFIG. 3. Southern blot of DNA extracted from the spleen (S) and CNS
the CTG start codon for pr75gag there was a single G r(C), 14 days after inoculation of KP, [03/ 4], or the phenotypic revertant
293. For the CNS samples, the entire brain, including brainstem and A point mutation (Fig. 5A). This alteration changed the
cerebellum, was extracted. Tissues from a normal uninoculated age- valine codon (GTG) to a methionine codon (ATG) creating
matched mouse (NL) were included as a control. Ten micrograms of a potential in-frame initiation codon with the sequence
DNA was digested with BamHI, which excises a 3.4-kb internal frag-
TTTATGG (Fig. 5A).ment from the viral genome. The blots were probed with WMXB (Portis
Evidence that the potential new start codon of 293 waset al., 1990), which hybridizes specifically to CasBrE viral envelope
sequences. actually utilized came from analysis of immunoblots with
AID VY 8293 / 6a26$$$$$1 11-13-96 14:43:55 vira AP: Virology
388 PORTIS, FUJISAWA, AND MCATEE
FIG. 5. (A) Comparison of the DNA sequence of KP, [03 / 4], and the phenotypic revertant 293 near the 5* end of the coding sequence of
glycosylated gag. Note that the mutations in [03 / 4] were preserved in 293. In addition, there was a G r A mutation 12 codons downstream of
the CTG start codon (in bold) which created a potential new initiation codon. (B) Location of the two peptides the antisera to which were used to
determine whether this potential initiation codon was actually used. Note that they straddle the V r M mutation. (C) Immunoblot of NP-40 lysates
from M. dunni infected with either 293 or KP and probed with rabbit anti-peptide 4215, 4210, or anti-CA. Note that gp85gag and its ca. 45-kDa
cleavage product react with all three antisera, whereas those of 293 react with only anti-4215 and anti-CA. (D) Immunoblot of PNGase-treated NP-
40 lysates of M. dunni cells infected with 293 or KP and probed with anti-CA antiserum. Note that the pr75gag band of 293 was of a slightly smaller
molecular size than that of KP, indicating that the protein of 293 was truncated.
anti-peptide antibodies specific for epitopes immediately formation of a new initiation site by a G r A mutation,
yielding a gp85gag with a 12-residue N-terminal truncation.upstream and downstream of the putative start site (i.e.,
peptides 4210 and 4215, respectively (Fig. 5B)). The In order to determine if the 293 virus was representa-
tive of phenotypic revertants which emerged in othergp85gag encoded by revertant 293 reacted with anti-CA
serum and anti-peptide 4215 but not with anti-peptide mice, animals were killed at either 57 or 155 days after
neonatal inoculation with [03 / 4] and frozen sections4210 (Fig. 5C). Wild-type gp85gag reacted with all three
antibodies. of their spleens were stained with anti-peptide 4210 and
anti-4215 (Fig. 6). Spleens from KP-infected mice, 14 daysAfter PNGase treatment to remove N-linked sugars, a
subtle, but clear difference was revealed in molecular sizes postinoculation, were included as controls. The high fre-
quency of infected cells in these spleens is seen in theof the glycosylated gag precursor protein (pr75gag) ex-
pressed by KP- and 293-infected cells (Fig. 5D). These re- sections stained for viral envelope protein (anti-SU). Con-
sistent with the immunoblots (Fig. 5) the majority of in-sults together indicate that the restoration of glycosylated
gag expression by virus 293 was a consequence of the fected cells in the spleen from the KP-inoculated mouse
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FIG. 6. Immunofluorescence detection of revertant virus expressed in the spleen of a mouse 57 days after neonatal ip inoculation of [03 / 4].
The spleen of a mouse 14 days after neonatal ip inoculation of KP is shown as a positive control and the spleen of an uninfected mouse 20 days
of age served as a negative control. These are low power photomicrographs of frozen sections of spleen stained with anti-envelope protein (SU)
antibody 667, as an indicator of the extent of infection, and anti-glycosylated gag antibodies 4210 and 4215, as an indicator of expression of
glycosylated gag. Anti-4210 and 4215 react with peptides flanking the putative new initiation codon for glycosylated gag found in revertant virus
293 (see legend of Fig. 5A). The expression of viral SU protein was widespread in the [03 / 4] spleen as was the expression of glycosylated gag
bearing the 4215 epitope. In contrast, only rare small collections of cells expressing glycosylated gag bearing the 4210 epitope were detected
(arrow). Glycosylated gag detected in the KP spleen expressed both epitopes. The staining pattern revealed that both viruses were localized primarily
in red pulp and the marginal zones of lymphoid follicles with relative sparing of the germinal centers.
stained with both anti-4210 and -4215. In contrast, spleen cells) as early as 5 days postinoculation. By 10
days postinoculation approximately 0.1% of the infectiouswhereas anti-4215 stained a major population of cells in
the spleen of the [03 / 4]-inoculated mouse 57 dpi, only centers expressed revertant virus but by 69 days postin-
oculation the frequency was ⁄50% (i.e., the frequencyrare groups of cells stained with anti-4210 (arrow). This
finding was consistent in our analysis of spleens from approached that of total infectious centers), a ratio which
was maintained for at least 142 days. Thus, revertantsone additional [03 / 4]-inoculated mouse 57 dpi as well
as 5 mice at 155 dpi. These results suggested that a emerged early after inoculation and spread progressively
within the spleen.major proportion of the glycosylated gag revertants
which emerged after inoculation of [03 / 4] had ac-
quired a start codon at the same location as that seen Phenotypic revertants were generated in vitro but
in revertant 293. There also appeared to be a minor popu- were not selected
lation of revertants which had acquired the epitope reac-
tive with anti-4210, possibly the result of a low frequency The emergence of revertants in vivo was likely a con-
sequence of the replicative advantage exhibited by vi-of true revertants, restoring the concensus sequence
about the CTG initiation codon for glycosylated gag. ruses expressing glycosylated gag (Portis et al., 1994).
In vitro, in M. dunni cells, however, glycosylated gagThe kinetics of emergence of revertants in the spleen
was quantified by infectious center assay using anti-SU appears to have no effect on virus replication or spread
(Portis et al., 1994). To test for emergence of revertantsantibody to measure total infectious centers and anti-
peptide 4215 to measure infectious centers expressing in vitro, M. dunni cells were infected with [03 / 4] and
the virus was sequentially passaged undiluted, so as torevertant virus (Fig. 7). Infectious centers expressing re-
vertant virus were detected at low levels (10 IC/106 avoid loss of rare revertants. After the 10th passage (35
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gained the capacity of the wild-type virus to spread to
the brain and induce neurologic disease. However, neu-
roinvasiveness was detected only after reinoculation of
revertants into neonates, since the mouse brain is sus-
ceptible to infection for only the first 10–12 days postna-
tally (Czub et al., 1992, 1991). Glycosylated gag, therefore,
appears to provide a selective advantage to the virus in
vivo by facilitating spread of virus both within the spleen
and to extra-splenic sites.
Despite the selective advantage provided by this pro-
tein in vivo, such was clearly not the case in vitro in M.
dunni fibroblasts. Thus, it is reasonable to conclude that
the function of glycosyalated gag exhibits some level of
cell or tissue specificity, perhaps through its interaction
with a cell-specific factor. Alternatively, the apparent lackFIG. 7. Frequency of splenic infectious centers expressing revertant
virus as a function of time after neonatal ip inoculation of [03 / 4]. of function of the protein in vitro could be due to expres-
The number of infectious centers per million spleen cells is expressed sion of a protein in M. dunni cells which complements
on the vertical axis as log10 . Total infectious centers were quantified the function of glycosylated gag.
using anti-SU antibody and infectious centers expressing revertant vi-
We fully expected that the phenotypic reversion wasrus were detected with antiserum to the glycosylated gag peptide 4215.
likely a consequence of recombination with endogenousNote that by 69 days postinoculation, the frequency of infectious cen-
ters expressing revertant virus equaled that for total virus indicating retroviral sequences, a form of genetic variation which
that ⁄50% of infectious centers expressed revertant virus at this time. occurs frequently in MuLV (Coffin, 1992; Katz and Skalka,
1990). However, this was apparently not the case, since
the revertants retained the two mutations of the [03 /
days after initial infection) a lysate of the infected cells
4] virus but showed a G r A substitution resulting in a
was analyzed by immunoblot with anti-CA antiserum
new translation initiation site 12 codons downstream
(Fig.8). No evidence of a gp85gag band was noted, sug-
from that of the wild-type virus. Although this new ATG
gesting that any revertants generated in vitro had not
was not embedded in an optimal ‘‘Kozak’’ consensus se-
emerged as a dominant species over the course of pas-
quence (Kozak, 1989), the suboptimal T at position 03
sage. Using infectivity assays, however, we were able
associated with an optimal G at position /4 has been
to detect revertant virus at low frequency. Shortly after
shown by mutational analysis to function adequately as
transfection of M. dunni cells with the viral DNA of [03
a translation initiation site (Kozak, 1986)./ 4] (after a confluent infection had been achieved) re-
The G r A mutation occurs by G-T mismatches during
vertants were already detectable in the supernatant by
viral DNA synthesis and is thought to occur either by
focus assay with anti-peptide 4215. The frequency was
ca. 1/5000 and after 20 cell-free passages, over a period
of 61 days, the frequency (1/1000) had not increased
significantly. As seen in vivo the majority of these re-
vertants reacted with anti-peptide 4215, and a minor pop-
ulation of anti-4210 reactive revertants was detected as
well. The contrast between the emergence of revertants
in vivo and the lack of selection in vitro provides strong
support for our previous finding that glycosylated gag
affected the kinetics of virus replication only in vivo but
not in vitro in either M. dunni or NIH3T3 fibroblasts.
DISCUSSION
In this report we have shown that within 1–2 weeks
after neonatal inoculation of mice with a nonpathogenic
mutant MuLV which lacks expression of glycosylated
gag, phenotypic revertants which had regained the ex-
FIG. 8. Immunoblot of a lysate from M. dunni cells after 10 cell-freepression of this protein were detected in the spleen. The
passages of [03 / 4]. The blot was probed with anti-CA antiserum.frequency of cells expressing revertant virus increased
For comparison are included a lysate from KP-infected as well as a
progressively until, by 69 days postinoculation, they ac- lysate from M. dunni cells infected with [03 / 4] prior to cell-free
counted for at least 50% of the infectious centers. The passage. There was no evidence for gp85gag in the lysate from the 10th
passage or from that taken at the 20th passage (not shown).revertant virus recovered from these mice had also re-
AID VY 8293 / 6a26$$$$$1 11-13-96 14:43:55 vira AP: Virology
391GLYCOSYLATED gag AND NEUROINVASIVENESS
dislocation mutagenesis (primer slippage) (Kunkel and which should provide clues to the function of glycosyl-
ated gag.Alexander, 1986) or simply misincorporation by the re-
verse transcriptase (Mendelman et al., 1990). In the for-
mer case one would expect an adenine either 5* or 3*
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